Sign inGet started

MCDADE MARK

Insider CIK 1242126 · FPRX Director · DERM Director · N/A Director · AIMT Director · ICVX Director · JSPR 10% owner · TALS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2820,000— $00SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2810,000— $00SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2816,800— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-28518— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-28183,177— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-28110,083— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-28448,431— $00SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2025-06-042025-06-0616,800— $016,800SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2024-06-052024-06-0710,000— $010,000SEC↗
ICVX Icosavax, Inc. D To issuer deriv2024-02-192024-02-2022,278— $00SEC↗
ICVX Icosavax, Inc. D To issuer deriv2024-02-192024-02-2017,000— $00SEC↗
ICVX Icosavax, Inc. U Tender2024-02-192024-02-203,510,228— $00SEC↗
ICVX Icosavax, Inc. U Tender2024-02-192024-02-2055,786— $00SEC↗
TRML Tourmaline Bio, Inc. P Buy2024-01-292024-01-31100,000$32.50 $3.25M448,431SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2023-10-232023-10-2320,000— $020,000SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2023-10-192023-10-2320,500— $00SEC↗
TRML Tourmaline Bio, Inc. A Award2023-10-192023-10-23518— $0518SEC↗
TRML Tourmaline Bio, Inc. A Award2023-10-192023-10-23348,431— $0348,431SEC↗
TALS Talaris Therapeutics, Inc. A Award deriv2023-06-132023-06-1420,500— $020,500SEC↗
ICVX Icosavax, Inc. A Award deriv2023-06-062023-06-0817,000— $017,000SEC↗
JSPR Jasper Therapeutics, Inc. P Buy2023-01-272023-04-112,666,666$1.50 $4.00M8,519,648SEC↗
ICVX Icosavax, Inc. A Award deriv2022-06-102022-06-1422,278— $022,278SEC↗
ICVX Icosavax, Inc. A Award2022-06-102022-06-145,543— $055,786SEC↗
TALS Talaris Therapeutics, Inc. A Award deriv2022-06-092022-06-1314,501— $014,501SEC↗
ICVX Icosavax, Inc. P Buy2022-04-012022-04-0542,225$7.10 $299.8K50,243SEC↗
ICVX Icosavax, Inc. C Conversion deriv2021-08-022021-08-0212,480,498— $00SEC↗
ICVX Icosavax, Inc. C Conversion deriv2021-08-022021-08-021,275,817— $00SEC↗
ICVX Icosavax, Inc. P Buy2021-08-022021-08-028,018$15.00 $120.3K3,518,246SEC↗
ICVX Icosavax, Inc. C Conversion2021-08-022021-08-023,310,228— $03,310,228SEC↗
ICVX Icosavax, Inc. P Buy2021-08-022021-08-02200,000$15.00 $3.00M3,510,228SEC↗
ICVX Icosavax, Inc. P Buy2021-08-022021-08-0213,333$15.00 $200.0K3,523,561SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1419,755$19.10 $377.3K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-14104,842$31.48 $3.30M0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1417,500$16.24 $284.2K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-147,500$1.71 $12.8K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1411,432$14.60 $166.9K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1415,398$17.39 $267.8K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer2020-10-132020-10-147,840$34.50 $270.5K0SEC↗
AIMT Aimmune Therapeutics, Inc. U Tender2020-10-102020-10-1426,852$34.50 $926.4K0SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2020-05-272020-05-2915,398— $015,398SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2020-05-272020-05-297,840— $034,692SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-246,000— $00SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-2423,275— $00SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-243,000— $00SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-246,000— $00SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-246,000— $00SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-2410,344— $00SEC↗
DERM Dermira, Inc. D To issuer deriv2020-02-202020-02-247,758— $00SEC↗
DERM Dermira, Inc. D To issuer2020-02-202020-02-246,000$18.75 $112.5K0SEC↗
DERM Dermira, Inc. M Exercise deriv2019-06-122019-06-143,000— $00SEC↗
DERM Dermira, Inc. M Exercise2019-06-122019-06-143,000— $06,000SEC↗
DERM Dermira, Inc. A Award deriv2019-06-042019-06-063,000— $03,000SEC↗
DERM Dermira, Inc. A Award deriv2019-06-042019-06-066,000— $06,000SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2019-05-232019-05-2811,432— $011,432SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2019-05-232019-05-286,442— $026,852SEC↗
NONE PHILLIPS EDISON GROCERY CE D To issuer2018-11-022018-11-066,465$22.54 $145.7K0SEC↗
N/A PHILLIPS EDISON GROCERY CE A Award2018-08-072018-08-081,097— $06,465SEC↗
DERM Dermira, Inc. M Exercise deriv2018-06-132018-06-143,000— $00SEC↗
DERM Dermira, Inc. M Exercise2018-06-132018-06-143,000— $03,000SEC↗
DERM Dermira, Inc. A Award deriv2018-06-122018-06-146,000— $06,000SEC↗
DERM Dermira, Inc. A Award deriv2018-06-122018-06-143,000— $03,000SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2018-05-232018-05-247,500— $07,500SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2018-05-232018-05-243,750— $020,410SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2018-05-102018-05-1410,000— $010,000SEC↗
N/A PHILLIPS EDISON GROCERY CE A Award2017-08-032017-11-131,100— $05,368SEC↗
DERM Dermira, Inc. A Award deriv2017-06-132017-06-153,000— $03,000SEC↗
DERM Dermira, Inc. A Award deriv2017-06-132017-06-156,000— $06,000SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2017-05-252017-05-3017,500— $017,500SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2017-05-102017-05-1210,000— $010,000SEC↗
FPRX FIVE PRIME THERAPEUTICS IN M Exercise deriv2016-10-032016-10-042,439— $00SEC↗
FPRX FIVE PRIME THERAPEUTICS IN M Exercise deriv2016-10-032016-10-0410,162— $00SEC↗
FPRX FIVE PRIME THERAPEUTICS IN M Exercise2016-10-032016-10-042,439$1.85 $4.5K12,601SEC↗
FPRX FIVE PRIME THERAPEUTICS IN M Exercise2016-10-032016-10-0410,162$1.23 $12.5K10,162SEC↗
N/A PHILLIPS EDISON GROCERY CE A Award2016-08-052016-08-091,112— $04,268SEC↗
DERM Dermira, Inc. A Award deriv2016-06-212016-06-2310,344— $010,344SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2016-05-252016-05-2719,755— $019,755SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2016-05-192016-05-2310,000— $00SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2016-03-152016-03-1710,000— $010,000SEC↗
AIMT Aimmune Therapeutics, Inc. P Buy2015-08-112015-08-1116,660$16.00 $266.6K16,660SEC↗
N/A PHILLIPS EDISON GROCERY CE P Buy2015-07-172015-07-17422$22.50 $9.5K3,156SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2015-06-122015-06-1612,500— $012,500SEC↗
DERM Dermira, Inc. A Award deriv2015-06-112015-06-157,758— $07,758SEC↗
N/A PHILLIPS EDISON GROCERY CE P Buy2015-05-062015-05-08422$22.50 $9.5K2,733SEC↗
DERM Dermira, Inc. A Award deriv2014-10-022014-10-0223,275— $023,275SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2014-05-162014-05-2012,500— $012,500SEC↗